343957-06-2

Basic information

• Product Name: 3-acetoxy-5-amino-4-methoxybenzoic acid
• Synonyms: 3-acetoxy-5-amino-4-methoxybenzoic acid;3-(acetyloxy)-5-amino-4-methoxybenzoic acid
• CAS NO: 343957-06-2
• Molecular Formula: C10H11NO5
• Molecular Weight: 225.19804
• Mol File: 343957-06-2.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-acetoxy-5-amino-4-methoxybenzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-acetoxy-5-amino-4-methoxybenzoic acid(343957-06-2)
• EPA Substance Registry System: 3-acetoxy-5-amino-4-methoxybenzoic acid(343957-06-2)

Safety Data

• Hazardous Substances Data: 343957-06-2(Hazardous Substances Data)

Upstream product

• 80547-88-2 3-acetoxy-4-methoxy-5-nitro-benzoic acid 

Downstream Products

• 1195945-02-8 3-acetoxy-5-fluoro-4-methoxy-benzoic acid 

Relevant articles and documents

Catechol O-Methyltransferase. 11. Inactivation by 5-Hydroxy-3-mercapto-4-methoxybenzoic Acid

5-Hydroxy-3-mercapto-4-methoxybenzoic acid was synthesized as a potential affinity-labeling reagent for catechol O-methyltransferase (COMT, EC 2.1.1.6).This compound was shown to produce noncompetitive inhibition of COMT when assayed in the presence or ab

ACYLAMINO-SUBSTITUTED FUSED CYCLOPENTANECARBOXYLIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS

The present invention relates to compounds of the formula (I), wherein A, Y, Z, R3 to R6, R20 to R22 and R50 have the meanings indicated in the claims, which are valuable pharmaceutical active compounds. Specifically, they are inhibitors of the endothelial differentiation gene receptor 2 (Edg-2, EDG2), which is activated by lysophosphatidic acid (LPA) and is also termed as LPA1 receptor, and are useful for the treatment of diseases such as atherosclerosis, myocardial infarction and heart failure, for example. The invention furthermore relates to processes for the preparation of the compounds of the formula (I), their use and pharmaceutical compositions comprising them.